Home > Boards > US Listed > Biotechs > PDS Biotech (PDSB)

winner winner chicken dinner sit back and enjoy

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Fress Member Profile
 
Followed By 204
Posts 2,603
Boards Moderated 0
Alias Born 02/10/17
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 11/30/2021 5:17:47 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 11/15/2021 4:11:18 PM
PDS Biotechnology EPS misses by $0.04 Seeking Alpha - 11/10/2021 7:17:31 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 7:17:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2021 7:06:24 AM
PDS Biotech Provides Business Update and Reports Third Quarter 2021 Financial Results GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
PDS Biotechnology Q3 2021 Earnings Preview Seeking Alpha - 11/9/2021 11:52:21 AM
PDS Biotechnology inks licensing agreement with National Cancer Institute Seeking Alpha - 11/8/2021 9:09:03 AM
PDS Biotechnology Licenses Protein for the Treatment of Acute Myeloid Leukemia, Prostate and Breast Cancers from National Cancer Institute GlobeNewswire Inc. - 11/8/2021 8:30:00 AM
PDS Biotech to license antigens from University of Georgia for universal flu vaccine Seeking Alpha - 11/1/2021 9:16:25 AM
PDS Biotech Announces Agreement with University of Georgia to License Novel Proteins for Versamune-based Universal Flu Vaccine GlobeNewswire Inc. - 11/1/2021 8:30:00 AM
PDS Biotech Chief Medical Officer, Lauren V. Wood, to Present at the 2021 International Head and Neck Cancer Conference GlobeNewswire Inc. - 10/27/2021 8:30:00 AM
PDS Biotechnology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 10/21/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/21/2021 7:46:25 AM
PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination GlobeNewswire Inc. - 10/21/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/20/2021 4:31:48 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/20/2021 4:31:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 4:07:24 PM
PDS Biotechnology Announces Conference Call and Webcast to Present Third-Quarter 2021 Financial Results GlobeNewswire Inc. - 10/13/2021 4:30:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/12/2021 4:30:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2021 8:46:31 AM
PDS Biotechnology Welcomes Matthew Hill as Chief Financial Officer GlobeNewswire Inc. - 10/6/2021 8:30:00 AM
PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial in Advanced HPV-16 Positive Head and Neck Cancer GlobeNewswire Inc. - 10/4/2021 8:30:00 AM
PDS Biotechnology to Present at the Benzinga Healthcare Conference GlobeNewswire Inc. - 9/27/2021 8:30:00 AM
PDS Biotechnology to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/22/2021 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences